PLAINSBORO TOWNSHIP, N.J. (AP) - In a July 9 story about Indian drugmaker Ranbaxy Laboratories Ltd., The Associated Press erroneously reported that the company will launch a generic version of acne drug Accutane in about six months. The product is slightly different than Accutane and will be sold under the brand name Absorica.
Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.